Tele: 561.316.3330
Breaking Medical Device News

Thursday, October 21, 2021

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR
HomeRedox Inc.Redox and Curative Partner to Connect COVID-19 Test Results to Public Health...

Redox and Curative Partner to Connect COVID-19 Test Results to Public Health Departments

Patient Data Integration Helps Inform Policies for Contact Tracing and Phased Openings

June 15, 2020

Redox, Inc., the leading interoperability platform for healthcare data exchange, is working with FDA-authorized COVID-19 testing company Curative to safely connect patient data to state public health departments for notification of results.

Redox notes since formalizing the partnership in May, the duo has kicked off projects with 24 states, with two, Illinois and Delaware, now fully live.

Other COVID-19 tests, such as the nasal swab and oral-based approach, are difficult for consumers to handle, are hard to administer en masse, or may pose a risk of exposure for healthcare workers. Curative offers an easy to use, accurate, and rapidly scalable oral fluid-based testing method that is less invasive, and which distributes results within just 48 hours. Using its connection with Redox, Curative immediately sends test results to state officials for reporting, contact tracing programs, and to inform policies as regions move through phases for opening the economy.

“Every state has its own unique, mandatory reporting requirements for COVID-19 testing. This can be challenging for an organization like ours, which is so focused on working as quickly as possible to scale up testing services nationwide,” said Isaac Turner, CIO and co-founder, Curative. “Redox has given us a secure and scalable integration strategy to quickly automate this reporting requirement across all the different systems we need to work with. Redox allows us to be confident that this critical data will get to the right destination, in the proper format, and in a timely manner, so we can continue to focus on scaling out COVID-19 testing across the nation.”

Redox standardizes healthcare data with a vendor-agnostic application programming interface (API) and a cloud network where organizations can exchange information. This networked approach to interoperability simplifies the way organizations exchange healthcare data by normalizing data formats and eliminating redundant connections. In this novel use case, Curative utilizes the Redox API to allow for a secure, efficient flow of data between it and public health authorities, further extending Redox’s network of more than 700 healthcare delivery organizations to include state public health agencies and regional HIEs.

“As we start to safely reopen the economy, state officials must have an accurate and efficient testing and contact tracing system,” said Niko Skievaski, co-founder and president of Redox. “Curative’s simpler, safer process has taken testing to a new level, and together with Redox, we’ll help to not only control the spread of the disease but also be better able to allocate healthcare resources appropriately. We hope this will become a core piece of public health infrastructure.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Contraline Closes $10.7 Million Series A Financing to Become a Clinical Stage Company

This infusion of capital will support the initiation of a first-in-human trial of ADAM™, the world’s first hydrogel implant designed to provide long-lasting, non-permanent contraception for men.

Adam S. Epstein New CEO of AliMed, Inc.

In his prior role as Chief Commercial Officer, Epstein directed all customer-facing, demand generation and product development activities. Under his new leadership, AliMed will continue to build a robust portfolio of contracted positions with major, national GPO’s, IDN’s, and Distribution partners to drive sales growth.

Tony Collins Appointed CFO of Xenter

“Xenter is building a platform for medical innovations that is transformational. The only way we can achieve our objectives is if we have great leaders like Tony Collins leading our company,” stated Richard J. Linder, Founder, Chairman & CEO of Xenter, Inc. “Tony brings incredible depth and experience to his new role as Chief Financial Officer.

Scott Sexton Appointed President at FIGUR8

"Scott brings to FIGUR8 30 years of workers' compensation, casualty, disability, and commercial health experience, most recently serving as a market leader for CorVel's national carrier practice sales team," said Nan-Wei Gong, CEO, and co-founder of FIGUR8.

Insulet Announces Board of Director Changes with Appointment of Luciana Borio, M.D. and Retirement of Sally W. Crawford

Luciana Borio MD is a respected physician with vast experience in advancing major regulatory and policy agendas for the United States.

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

By using this website you agree to accept Medical Device News Magazine Privacy Policy